Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis. Prosperini L, Fanelli F, Pozzilli C J Neurol Sci. 2016 May 15; 364:145-7. Epub 2016 Mar 16. PMID: 27084235. Abstract CommentRecommendBookmarkWatch